We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
FDA Requires New Class Warnings for All Gadolinium-Based Contrast Agents
FDA Review: Adding LABAs to ICS Treatment Does Not Significantly Increase Serious Asthma Outcomes Risk
Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study
The FDA's Adverse Event Reporting System (FAERS) Public Dashboard
Brian P. McDonough, MD, FAAFP
Food-Proof: A USDA Expert's Tips for Avoiding Food Poisoning
FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma
FDA D.I.S.C.O.: Niraparib in Ovarian Cancer
FDA D.I.S.C.O.: Rucaparib in Ovarian Cancer
FDA Confirms Leg and Foot Amputation Risk with Diabetes Medicine Canagliflozin
Introducing FDA's Drug Information Soundcast in Clinical Oncology (DISCO)
Study Examines Effectiveness of Steroid Medication for Sore Throat
Dosing Practices in sHPT
You need to be logged in to save this episode to a playlist.
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education